Fumiyo Nakagawa

Summary

Affiliation: University College London
Country: UK

Publications

  1. doi request reprint Projected life expectancy of people with HIV according to timing of diagnosis
    Fumiyo Nakagawa
    HIV Epidemiology and Biostatistics Group, Research Department of Infection and Population Health, University College London, UK
    AIDS 26:335-43. 2012
  2. doi request reprint Life expectancy living with HIV: recent estimates and future implications
    Fumiyo Nakagawa
    Research Department of Infection and Population Health, UCL, London, UK
    Curr Opin Infect Dis 26:17-25. 2013
  3. pmc Projected Lifetime Healthcare Costs Associated with HIV Infection
    Fumiyo Nakagawa
    Research Department of Infection and Population Health, UCL, London, United Kingdom
    PLoS ONE 10:e0125018. 2015
  4. doi request reprint Potential impact on HIV incidence of higher HIV testing rates and earlier antiretroviral therapy initiation in MSM
    Andrew N Phillips
    aUCL bLondon School of Hygiene and Tropical Medicine cPublic Health England PHE dCity University London, London, UK eRigshospitalet, University of Copenhagen, Denmark fHIV i Base, London, UK
    AIDS 29:1855-62. 2015
  5. pmc Effectiveness and cost-effectiveness of potential responses to future high levels of transmitted HIV drug resistance in antiretroviral drug-naive populations beginning treatment: modelling study and economic analysis
    Andrew N Phillips
    Research Department of Infection and Population Health, University College London, London, UK Electronic address
    Lancet HIV 1:e85-93. 2014
  6. pmc A Method to Estimate the Size and Characteristics of HIV-positive Populations Using an Individual-based Stochastic Simulation Model
    Fumiyo Nakagawa
    From the aResearch Department of Infection and Population Health, UCL, London, United Kingdom bStichting HIV Monitoring, Amsterdam, The Netherlands cInserm, centre Inserm U897, Bordeaux, France dDepartment of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom eDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden fDepartment of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden gEuropean Centre for Disease Prevention and Control ECDC, Stockholm, Sweden hCEEISCAT, Generalitat de Catalunya, Barcelona, Spain iWHO Regional Office for Europe, Copenhagen, Denmark jInstitute of Clinical Trials and Methodology, UCL, London, United Kingdom kDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland lResearch Department of Primary Care and Population Health, UCL, London, United Kingdom mCHIP Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark nDepartment of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, Athens, Greece oUCL Institute of Child Health, UCL, London
    Epidemiology 27:247-56. 2016
  7. pmc Potential future impact of a partially effective HIV vaccine in a southern African setting
    Andrew N Phillips
    Research Department of Infection and Population Health, University College London, London, United Kingdom
    PLoS ONE 9:e107214. 2014
  8. pmc Cost-effectiveness of HIV drug resistance testing to inform switching to second line antiretroviral therapy in low income settings
    Andrew Phillips
    Research Department of Infection and Population Health, UCL, London, United Kingdom
    PLoS ONE 9:e109148. 2014
  9. pmc Estimating HIV Incidence, Time to Diagnosis, and the Undiagnosed HIV Epidemic Using Routine Surveillance Data
    Ard van Sighem
    aStichting HIV Monitoring, Amsterdam, The Netherlands bUniversity College London, London, United Kingdom cMRC Biostatistics Unit, Cambridge, United Kingdom dEuropean Centre for Disease Prevention and Control, Stockholm, Sweden eNational Institute for Public Health and the Environment, Bilthoven, The Netherlands fInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland and gDepartment of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, United Kingdom
    Epidemiology 26:653-60. 2015
  10. pmc Use of surveillance data on HIV diagnoses with HIV-related symptoms to estimate the number of people living with undiagnosed HIV in need of antiretroviral therapy
    Rebecca K Lodwick
    Research Department of Primary Care and Population Health, University College London, London, United Kingdom
    PLoS ONE 10:e0121992. 2015

Detail Information

Publications12

  1. doi request reprint Projected life expectancy of people with HIV according to timing of diagnosis
    Fumiyo Nakagawa
    HIV Epidemiology and Biostatistics Group, Research Department of Infection and Population Health, University College London, UK
    AIDS 26:335-43. 2012
    ..Our aims were to estimate the life expectancy of an HIV-infected MSM living in a developed country with extensive access to ART and healthcare, and to assess the effect of late diagnosis on life expectancy...
  2. doi request reprint Life expectancy living with HIV: recent estimates and future implications
    Fumiyo Nakagawa
    Research Department of Infection and Population Health, UCL, London, UK
    Curr Opin Infect Dis 26:17-25. 2013
    ..Here, we review the latest literature on estimates of life expectancy and consider the implications for future research...
  3. pmc Projected Lifetime Healthcare Costs Associated with HIV Infection
    Fumiyo Nakagawa
    Research Department of Infection and Population Health, UCL, London, United Kingdom
    PLoS ONE 10:e0125018. 2015
    ..We evaluate the additional lifetime healthcare cost incurred due to living with HIV...
  4. doi request reprint Potential impact on HIV incidence of higher HIV testing rates and earlier antiretroviral therapy initiation in MSM
    Andrew N Phillips
    aUCL bLondon School of Hygiene and Tropical Medicine cPublic Health England PHE dCity University London, London, UK eRigshospitalet, University of Copenhagen, Denmark fHIV i Base, London, UK
    AIDS 29:1855-62. 2015
    ..We investigated what would be required to reduce HIV incidence in MSM to below 1 per 1000 person-years (i.e. <535 new infections per year) by 2030, and whether this is likely to be cost-effective...
  5. pmc Effectiveness and cost-effectiveness of potential responses to future high levels of transmitted HIV drug resistance in antiretroviral drug-naive populations beginning treatment: modelling study and economic analysis
    Andrew N Phillips
    Research Department of Infection and Population Health, University College London, London, UK Electronic address
    Lancet HIV 1:e85-93. 2014
    ..We aimed to compare the effectiveness and cost-effectiveness of different potential public health responses to substantial levels of transmitted drug resistance...
  6. pmc A Method to Estimate the Size and Characteristics of HIV-positive Populations Using an Individual-based Stochastic Simulation Model
    Fumiyo Nakagawa
    From the aResearch Department of Infection and Population Health, UCL, London, United Kingdom bStichting HIV Monitoring, Amsterdam, The Netherlands cInserm, centre Inserm U897, Bordeaux, France dDepartment of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom eDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden fDepartment of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden gEuropean Centre for Disease Prevention and Control ECDC, Stockholm, Sweden hCEEISCAT, Generalitat de Catalunya, Barcelona, Spain iWHO Regional Office for Europe, Copenhagen, Denmark jInstitute of Clinical Trials and Methodology, UCL, London, United Kingdom kDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland lResearch Department of Primary Care and Population Health, UCL, London, United Kingdom mCHIP Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark nDepartment of Hygiene, Epidemiology and Medical Statistics, University of Athens Medical School, Athens, Greece oUCL Institute of Child Health, UCL, London
    Epidemiology 27:247-56. 2016
    ..We demonstrate that our method can be applied to settings with less data, however plausibility ranges for estimates will be wider to reflect greater uncertainty of the data used to fit the model. ..
  7. pmc Potential future impact of a partially effective HIV vaccine in a southern African setting
    Andrew N Phillips
    Research Department of Infection and Population Health, University College London, London, United Kingdom
    PLoS ONE 9:e107214. 2014
    ....
  8. pmc Cost-effectiveness of HIV drug resistance testing to inform switching to second line antiretroviral therapy in low income settings
    Andrew Phillips
    Research Department of Infection and Population Health, UCL, London, United Kingdom
    PLoS ONE 9:e109148. 2014
    ....
  9. pmc Estimating HIV Incidence, Time to Diagnosis, and the Undiagnosed HIV Epidemic Using Routine Surveillance Data
    Ard van Sighem
    aStichting HIV Monitoring, Amsterdam, The Netherlands bUniversity College London, London, United Kingdom cMRC Biostatistics Unit, Cambridge, United Kingdom dEuropean Centre for Disease Prevention and Control, Stockholm, Sweden eNational Institute for Public Health and the Environment, Bilthoven, The Netherlands fInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland and gDepartment of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, United Kingdom
    Epidemiology 26:653-60. 2015
    ..Estimates of the size of the undiagnosed HIV-infected population are important to understand the HIV epidemic and to plan interventions, including "test-and-treat" strategies...
  10. pmc Use of surveillance data on HIV diagnoses with HIV-related symptoms to estimate the number of people living with undiagnosed HIV in need of antiretroviral therapy
    Rebecca K Lodwick
    Research Department of Primary Care and Population Health, University College London, London, United Kingdom
    PLoS ONE 10:e0121992. 2015
    ..It is important to have methods available to estimate the number of people who have undiagnosed HIV and are in need of antiretroviral therapy (ART)...
  11. pmc Increased HIV incidence in men who have sex with men despite high levels of ART-induced viral suppression: analysis of an extensively documented epidemic
    Andrew N Phillips
    Research Department of Infection and Population Health, UCL, London, United Kingdom
    PLoS ONE 8:e55312. 2013
    ....
  12. pmc Sustainable HIV treatment in Africa through viral-load-informed differentiated care
    Andrew Phillips
    Department of Infection and Population Health, University College London, Rowland Hill Street, London NW3 2PF, UK
    Nature 528:S68-76. 2015
    ..We also explore the potential benefits of point-of-care viral load tests that may become available in the future...